Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01332578Phase 4Completed
Phase 4, randomised, open-label trial of acetaminophen in influenza and common cold (2 arms), sponsored by GSK. Primary endpoint: Time to Reach Plasma Paracetamol Concentration of 0.25 μg/mL. Started May 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01332578.